(5E)-5-(3-hydroxybenzylidene)-1,3-thiazolidine-2,4-dione, 95.0%, 1g

(S)-1-(4-Bromo-3-fluorophenyl)ethanamine, 98%, 100mg

Clorhidrato de 1-adamantilamina, mínimo 99 %, para síntesis, 100 g, envase de plástico.

(R)-Cyclopropyl(phenyl)methanamine, 95.0%, 100mg

4-Ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione, 98%, 100mg

methyl quinuclidine-4-carboxylate;hydrochloride, 5g

alpha-D-Lactose monohydrate, 95.0%, 250g

(-)-Arctigenin>95.0%(GC)10mg

(4-Bromo-2,5-dimethoxyphenyl)boronic acid, 95.0%, 100mg

7-(tert-Butyl) 2-ethyl 3-bromo-5,6-dihydroimidazo[1,2-a]pyrazine-2,7(8H)-dicarboxylate, 95%, 250mg

Placas de microtitulación inertes Fondo de grado F, transparente estéril 40 uds.

1-(3,5-Dimethylphenyl)cyclopropanamine hydrochloride, 5g

2-(2-Aminoacetamido)-4-methylpentanoic acid, 95.0%, 100g